Automated Insulin Delivery in Type 1 Diabetes Management

Diabetology

Automated insulin delivery (AID) systems are transforming type 1 diabetes management by integrating continuous glucose monitoring, insulin pumps, and control algorithms to adjust insulin delivery based on glucose trends. These systems can improve time in range, reduce glycemic variability, and help limit hypoglycemic episodes, while reducing some aspects of day-to-day diabetes management burden. Clinical implementation requires appropriate patient selection, education, device training, and ongoing review of glucose data and insulin settings. Understanding system types, algorithm performance, user responsibilities, and potential limitations is essential for safe and effective use. Individualized treatment and regular follow-up remain important to optimize glycemic outcomes, support self-management, and improve quality of life. Please participate in the survey and share your opinion on automated insulin delivery in type 1 diabetes management.

In your opinion, what is the biggest benefit of automated insulin delivery systems?

• Improved time in range
• Reduced insulin requirements
• Complete prevention of hypoglycemia
• Elimination of glucose monitoring

Do you think AID systems will become a standard component of type 1 diabetes management?

• Strongly agree
• Agree
• Disagree
• Not sure